Alnylam Pharmaceuticals Aktie
263,40
EUR
-6,30
EUR
-2,34
%
307,14
USD
-5,15
USD
-1,65
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung